Gender-Specific Interplay of Signaling through β-Catenin and CAR in the Regulation of Xenobiotic-Induced Hepatocyte Proliferation

A new mathematical model for relative quantification in real-time RT-PCR

Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · see citing works

β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin

Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G., & Birchmeier, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00336-1 · Cited by 1,352 · see citing works

Induction of phase I, II and III drug metabolism/transport by xenobiotics

Xu, C., Li, C. Y.-T., & Kong, A. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,272 · see citing works

Apc Tumor Suppressor Gene Is the “Zonation-Keeper” of Mouse Liver

Benhamouche, S., Decaens, T., Godard, C., Chambrey, R., Rickman, D. S., Moinard, C., Vasseur-Cognet, M., Kuo, C. J., Kahn, A., Perret, C., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.015 · Cited by 543 · see citing works

Androstane metabolites bind to and deactivate the nuclear receptor CAR-β

FORMAN, B. M., Tzameli, I., Choi, H., Chen, J., Simha, D., Seol, W., Evans, R. M., & Moore, D. D. (1998) · Nature · doi:10.1038/26996 · Cited by 476 · see citing works

Diverse Roles of the Nuclear Orphan Receptor CAR in Regulating Hepatic Genes in Response to Phenobarbital

Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 465 · see citing works

Conditional Deletion of β-Catenin Reveals Its Role in Liver Growth and Regeneration

Tan, X., Behari, J., Cieply, B., Michalopoulos, G. K., & Monga, S. P. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.042 · Cited by 361 · see citing works

pp90rsk1 Regulates Estrogen Receptor-Mediated Transcription through Phosphorylation of Ser-167

Joel, P. B., Smith, J. A., Sturgill, T. W., Fisher, T. L., Blenis, J., & Lannigan, D. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.4.1978 · Cited by 345 · see citing works

Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas

Colnot, S., Decaens, T., Niwa‐Kawakita, M., Godard, C., Hamard, G., Kahn, A., Giovannini, M., & Perret, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404761101 · Cited by 326 · see citing works

Liver‐specific loss of β‐catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice†‡

Sekine, S., Lan, B. Y., Bedolli, M., Feng, S., & Hebrok, M. (2006) · Hepatology · doi:10.1002/hep.21131 · Cited by 295 · see citing works

Forkhead Box M1B Transcriptional Activity Requires Binding of Cdk-Cyclin Complexes for Phosphorylation-Dependent Recruitment of p300/CBP Coactivators

Major, M. L., Lepe, R., & Costa, R. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2649-2661.2004 · Cited by 267 · see citing works

Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase #

Apte, U. M., Gkretsi, V., Bowen, W. C., Mars, W. M., Luo, J., Donthamsetty, S., Orr, A., Monga, S. P., Wu, C., & Michalopoulos, G. K. (2009) · Hepatology · doi:10.1002/hep.23059 · Cited by 173 · see citing works

Estrogen Activation of the Nuclear Orphan Receptor CAR (Constitutive Active Receptor) in Induction of the Mouse <i>Cyp2b10</i> Gene

Kawamoto, T., Kakizaki, S., Yoshinari, K., & Negishi, M. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0547 · Cited by 168 · see citing works

Wnt Signaling in Liver Cancer

Takigawa, Y., & Brown, A. (2008) · Current Drug Targets · doi:10.2174/138945008786786127 · Cited by 156 · see citing works

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

Millour, J., Constantinidou, D., Stavropoulou, A. V., Wilson, M., Myatt, S. S., Kwok, J. M.-M., Sivanandan, K., Coombes, R. C., Medema, R. H., Hartman, J., et al. (2010) · Oncogene · doi:10.1038/onc.2010.47 · Cited by 155 · see citing works

Liver-specific loss of β-catenin results in delayed hepatocyte proliferation after partial hepatectomy

Sekine, S., Gutiérrez, P. J. A., Lan, B. Y., Feng, S., & Hebrok, M. (2007) · Hepatology · doi:10.1002/hep.21523 · Cited by 153 · see citing works

Zonal gene expression in murine liver: Lessons from tumors

Hailfinger, S., Jaworski, M., Braeuning, A., Buchmann, A., & Schwarz, M. (2006) · Hepatology · doi:10.1002/hep.21082 · Cited by 142 · see citing works

C‐Myc and its target FoxM1 are critical downstream effectors of constitutive androstane receptor (CAR) mediated direct liver hyperplasia†

Blanco‐Bose, W. E., Murphy, M. J., Ehninger, A., Offner, S., Dubey, C., Huang, W., Moore, D. D., & Trumpp, A. (2008) · Hepatology · doi:10.1002/hep.22475 · Cited by 138 · see citing works

CAR, Driving into the Future

Swales, K. E., & Negishi, M. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0397 · Cited by 137 · see citing works

Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous.

Kemp, C. J., Leary, C., & Drinkwater, N. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7505 · Cited by 99 · see citing works

Early Increase in Cyclin-D1 Expression and Accelerated Entry of Mouse Hepatocytes into S Phase after Administration of the Mitogen 1,4-Bis[2-(3,5-Dichloropyridyloxy)] Benzene

Ledda-Columbano, G. M., Pibiri, M., Loi, R., Perra, A., Shinozuka, H., & Columbano, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64709-8 · Cited by 94 · see citing works

Wnt/β-catenin signaling in hepatic organogenesis

Nejak-Bowen, K., & Monga, S. P. S. (2008) · Organogenesis · doi:10.4161/org.4.2.5855 · Cited by 92 · see citing works

Sexually dimorphic regulation and induction of P450s by the constitutive androstane receptor (CAR)

Hernandez, J. P., Mota, L. C., Huang, W., Moore, D. D., & Baldwin, W. S. (2008) · Toxicology · doi:10.1016/j.tox.2008.11.002 · Cited by 85 · see citing works

Inducibility of Drug-Metabolizing Enzymes by Xenobiotics in Mice with Liver-Specific Knockout of Ctnnb1

Braeuning, A., Sanna, R., Huelsken, J., & Schwarz, M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.026179 · Cited by 82 · see citing works

Phenobarbital Confers its Diverse Effects by Activating the Orphan Nuclear Receptor Car

Kodama, S., & Negishi, M. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569851 · Cited by 77 · see citing works

Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice.

Kemp, C. J., & Drinkwater, N. R. (1989) · PubMed · Cited by 76 · see citing works

Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP

Columbano, A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg063 · Cited by 60 · see citing works

Review Article: Paradoxical Effects of Phenobarbital on Mouse Hepatocarcinogenesis

Lee, G. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800201 · Cited by 58 · see citing works

RSK in tumorigenesis: Connections to steroid signaling

Eisinger‐Mathason, T. S. K., Andrade, J., & Lannigan, D. A. (2010) · Steroids · doi:10.1016/j.steroids.2009.12.010 · Cited by 55 · see citing works

Orphan Nuclear Receptor Constitutive Active/Androstane Receptor–Mediated Alterations in DNA Methylation during Phenobarbital Promotion of Liver Tumorigenesis

Phillips, J. M., Yamamoto, Y., Negishi, M., Maronpot, R. R., & Goodman, J. I. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl188 · Cited by 47 · see citing works

Different Proliferative Activity in Vitro of Periportal and Perivenous Hepatocytes

Gebhardt, R. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809095909 · Cited by 47 · see citing works

Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Poole, T. M., & Drinkwater, N. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5848 · Cited by 47 · see citing works

Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP

Columbano, A., Ledda‐Columbano, G. M., Pibiri, M., Piga, R., Shinozuka, H., Luca, V. D., Cerignoli, F., & Tripodi, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200891 · Cited by 46 · see citing works

Dual action of oestrogens on the mouse constitutive androstane receptor

MÄKINEN, J., REINISALO, M., NIEMI, K., VIITALA, P., JYRKKÄRINNE, J., CHUNG, H., PELKONEN, O., & HONKAKOSKI, P. (2003) · Biochemical Journal · doi:10.1042/bj20030553 · Cited by 45 · see citing works

β-Catenin as a multilayer modulator of zonal cytochrome P450 expression in mouse liver

Braeuning, A., & Schwarz, M. (2009) · Biological Chemistry · doi:10.1515/bc.2010.012 · Cited by 39 · see citing works

Phenotype and growth behavior of residual β-catenin-positive hepatocytes in livers of β-catenin-deficient mice

Braeuning, A., Singh, Y., Rignall, B., Buchmann, A., Hammad, S., Othman, A., von Recklinghausen, I., Godoy, P., Hoehme, S., Drasdo, D., et al. (2010) · Histochemistry and Cell Biology · doi:10.1007/s00418-010-0747-1 · Cited by 39 · see citing works

The CAR Nuclear Receptor and Hepatocyte Proliferation * #

Costa, R. H., Kalinchenko, V. V., Tan, Y., & Wang, I. (2005) · Hepatology · doi:10.1002/hep.20953 · Cited by 35 · see citing works

Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility

Bursch, W., Chabicovsky, M., Wastl, U., Grasl‐Kraupp, B., Bukowska, K., Taper, H. S., & Schulte‐Hermann, R. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi129 · Cited by 35 · see citing works

Novel functional profiling approach combining reverse phase protein microarrays and human 3‐D ex vivo tissue cultures: Expression of apoptosis‐related proteins in human colon cancer

Pirnia, F., Pawlak, M., Thallinger, G., Gierke, B., Templin, M. F., KAPPELER, A., Betticher, D. C., Gloor, B., & Borner, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800159 · Cited by 32 · see citing works

Inhibition of gap-junctional-intercellular communication in intact rat liver by nongenotoxic hepatocarcinogens

Kolaja, K. L., Engelken, D. T., & Klaassen, C. D. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00162-1 · Cited by 32 · see citing works

Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene

Donthamsetty, S., Bhave, V., Kliment, C. R., Bowen, W. C., Mars, W. M., Bell, A. W., Stewart, R. E., Orr, A. V., Wu, C., & Michalopoulos, G. K. (2010) · Hepatology · doi:10.1002/hep.24040 · Cited by 30 · see citing works

Liver-Specific Ablation of Integrin-Linked Kinase in Mice Results in Enhanced and Prolonged Cell Proliferation and Hepatomegaly after Phenobarbital Administration

Donthamsetty, S., Bowen, W. C., Mars, W. M., Bhave, V., Luo, J., Wu, C., Hurd, J., Orr, A., Bell, A. W., & Michalopoulos, G. K. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp281 · Cited by 23 · see citing works

Regulation of the FOXM1 transcription factor by the estrogen receptor alpha at the protein level, in breast cancer.

Karadedou, C. T. (2006) · PubMed Central · Cited by 18 · see citing works

1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) and related compounds as inducers of hepatic monooxygenases

Kelley, M. J., Lambert, I. B., Merrill, J. C., & Safe, S. H. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90722-1 · Cited by 16 · see citing works

Estrogen modulates transactivations of SXR-mediated liver X receptor response element and CAR-mediated phenobarbital response element in HepG2 cells

Min, G. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.11.074 · Cited by 8 · see citing works

Liver zonation: Novel aspects of its regulation and its impact on homeostasis

Gebhardt, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8491 · Cited by 275 · see citing works

FOXM1 (Forkhead box M1) in Tumorigenesis

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 183 · see citing works

The Transcription Factor FOXM1 (Forkhead box M1)

Wierstra, I. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-407173-5.00004-2 · Cited by 174 · see citing works

Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis

Dong, B., Lee, J.-S., Park, Y.-Y., Yang, F., Xu, G., Huang, W., Finegold, M. J., & Moore, D. D. (2015) · Nature Communications · doi:10.1038/ncomms6944 · Cited by 97 · see citing works

Genetic lineage tracing analysis of the cell of origin of hepatotoxin‐induced liver tumors in mice

Shin, S., Wangensteen, K. J., Teta‐Bissett, M., Wang, Y. J., Mosleh‐Shirazi, E., Buza, E. L., Greenbaum, L. E., & Kaestner, K. H. (2016) · Hepatology · doi:10.1002/hep.28602 · Cited by 86 · see citing works

Phenobarbital-Mediated Tumor Promotion in Transgenic Mice with Humanized CAR and PXR

Braeuning, A., Gavrilov, A., Brown, S., Wolf, C. R., Henderson, C. J., & Schwarz, M. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu099 · Cited by 57 · see citing works

The Connection of Azole Fungicides with Xeno-Sensing Nuclear Receptors, Drug Metabolism and Hepatotoxicity

Marx‐Stoelting, P., Knebel, C., & Braeuning, A. (2020) · Cells · doi:10.3390/cells9051192 · Cited by 54 · see citing works

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

Romualdo, G. R., Leroy, K., Costa, C. J. S., Bacil, G. P., Vanderborght, B., da Silva, T. C., Barbisan, L. F., Andraus, W., Devisscher, L., Câmara, N. O. S., et al. (2021) · Cancers · doi:10.3390/cancers13215583 · Cited by 52 · see citing works

TCPOBOP‐Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling

Bhushan, B., Stoops, J. W., Mars, W. M., Orr, A., Bowen, W. C., Paranjpe, S., & Michalopoulos, G. K. (2019) · Hepatology · doi:10.1002/hep.30109 · Cited by 49 · see citing works

Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model

Delgado, E. R., Okabe, H., Preziosi, M., Russell, J. O., Alvarado, T. F., Oertel, M., Nejak‐Bowen, K. N., Zhang, Y., & Monga, S. P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.021 · Cited by 48 · see citing works

Coordinating Role of RXRα in Downregulating Hepatic Detoxification during Inflammation Revealed by Fuzzy-Logic Modeling

Keller, R., Klein, M., Thomas, M., Dräger, A., Metzger, U., Templin, M. F., Joos, T. O., Thasler, W. E., Zell, A., & Zanger, U. M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004431 · Cited by 40 · see citing works

Mechanisms of RAS/β-catenin interactions

Zeller, E., Hammer, K., Kirschnick, M., & Braeuning, A. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1035-3 · Cited by 39 · see citing works

Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells

Thomas, M., Bayha, C., Vetter, S., Hofmann, U., Schwarz, M., Zanger, U. M., & Braeuning, A. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097402 · Cited by 39 · see citing works

Ha‐ras and β‐catenin oncoproteins orchestrate metabolic programs in mouse liver tumors

Unterberger, E. B., Eichner, J., Wrzodek, C., Lempiäinen, H., Luisier, R., Terranova, R., Metzger, U., Plummer, S. M., Knorpp, T., Braeuning, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28798 · Cited by 35 · see citing works

Loss of hepatocyte β-catenin protects mice from experimental porphyria-associated liver injury

Saggi, H., Maitra, D., Jiang, A., Zhang, R., Wang, P., Cornuet, P. K., Singh, S., Locker, J. D., Ma, X., Dailey, H. A., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.023 · Cited by 34 · see citing works

Clinical Relevance of the Constitutive Androstane Receptor

Stern, S., Kurian, R., & Wang, H. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000483 · Cited by 29 · see citing works

Nuclear receptor CAR-mediated liver cancer and its species differences

Shizu, R., & Yoshinari, K. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1746268 · Cited by 29 · see citing works

The time point of β-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor

Ganzenberg, K., Singh, Y., & Braeuning, A. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.019 · Cited by 29 · see citing works

Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans?

Braeuning, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1331-6 · Cited by 25 · see citing works

Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice

Braeuning, A., Gavrilov, A., Geissler, M., Wenz, C., Colnot, S., Templin, M. F., Metzger, U., Römer, M., Zell, A., & Schwarz, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1667-1 · Cited by 23 · see citing works

Bovine NR1I3 gene polymorphisms and its association with feed efficiency traits in Nellore cattle

Alexandre, P. A., Gomes, R. D. C., Santana, M. H. D. A., Silva, S. D. L. E., Leme, P. R., Mudadu, M. A., Regitano, L. C. D. A., Meirelles, F. V., Ferraz, J. B. S., & Fukumasu, H. (2014) · Meta Gene · doi:10.1016/j.mgene.2014.01.003 · Cited by 23 · see citing works

Current view of liver cancer cell-of-origin and proposed mechanisms precluding its proper determination

Gromowski, T., Lukacs‐Kornek, V., & Cisowski, J. (2023) · Cancer Cell International · doi:10.1186/s12935-022-02843-0 · Cited by 23 · see citing works

Role of the constitutive androstane receptor (CAR) in human liver cancer

Bae, S. D. W., Nguyen, R., Qiao, L., & George, J. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188516 · Cited by 22 · see citing works

Regulation of expression of drug-metabolizing enzymes by oncogenic signaling pathways in liver tumors: a review

Braeuning, A., & Schwarz, M. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.06.013 · Cited by 19 · see citing works

Role of CYP2B in Phenobarbital-Induced Hepatocyte Proliferation in Mice

Li, L., Bao, X., Zhang, Q.-Y., Negishi, M., & Ding, X. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.076406 · Cited by 17 · see citing works

Nuclear Receptor CAR Suppresses GADD45B-p38 MAPK Signaling to Promote Phenobarbital-induced Proliferation in Mouse Liver

Hori, T., Saito, K., Moore, R., Flake, G. P., & Negishi, M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0118 · Cited by 17 · see citing works

The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation

Yamada, T., Cohen, S. M., & Lake, B. G. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2513332 · Cited by 14 · see citing works

β-catenin signaling, the constitutive androstane receptor and their mutual interactions

Braeuning, A., & Pávek, P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02935-8 · Cited by 13 · see citing works

Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver

Sprenger, H., Rasinger, J. D., Hammer, H., Naboulsi, W., Zabinsky, E., Planatscher, H., Schwarz, M., Poetz, O., & Braeuning, A. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03338-7 · Cited by 12 · see citing works

Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation.

Yarushkin, A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E., & Pustylnyak, V. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173135 · Cited by 8 · see citing works

The connection of β-catenin and phenobarbital in murine hepatocarcinogenesis: a critical discussion of Awuah et al., PLoS ONE 7(6):e39771, 2012

Braeuning, A. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-1002-4 · Cited by 7 · see citing works

Stilbene compound trans-3,4,5,4´-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver

Dusek, J., Škoda, J., Holas, O., Štefela, A., Smutný, T., Linhartová, L., Hirsova, P., Kučera, O., Mičuda, S., Braeuning, A., et al. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.05.024 · Cited by 6 · see citing works

Phenobarbital inhibits calpain activity and expression in mouse hepatoma cells

Groll, N., Kollotzek, F., Goepfert, J. C., Joos, T. O., Schwarz, M., & Braeuning, A. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0223 · Cited by 5 · see citing works

Array-based Western-blotting reveals spatial differences in hepatic signaling and metabolism following CAR activation

Treindl, F., Zabinsky, E., Kling, S., Schwarz, M., Braeuning, A., & Templin, M. F. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02680-y · Cited by 5 · see citing works

Impact of nanomedicine on hepatic cytochrome P450 3A4 activity: things to consider during pre-clinical and clinical studies

Jonsson‐Schmunk, K., Schafer, S. C., & Croyle, M. A. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0376-y · Cited by 4 · see citing works

Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation

Braeuning, A., Kollotzek, F., Zeller, E., Knorpp, T., Templin, M. F., & Schwarz, M. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083014 · Cited by 2 · see citing works

The slow elimination of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene in mice leads to prolonged constitutive androstane receptor activation and hepatomegaly

Gao, Y., Cai, C., Zheng, W., Fan, S., Zhang, Y., Zhou, Y., Li, H., Yang, J., Guan, S., & Bi, H. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100092 · Cited by 1 · see citing works

Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration

Zhou, W., Chembazhi, U. V., Huang, J., Bangru, S., Dean, A. E., Asokakumar, A., Kalsotra, A., Rudnick, D. A., & Anakk, S. (2026) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2026.101858

Letter to the editor regarding the review article: Yamada T, Cohen SM, Lake BG. The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation. Crit Rev Toxicol. 2025;55(5):549–586. doi: 10.1080/10408444.2025.2513332

Wolf, C. R., Henderson, C. J., Schwarz, M., Inesta-Vaquera, F., & Meehan, R. R. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2601199

Les effets d'une co-exposition à des PCBs (DL et non DL) et au benzo(a)pyrène sur l’adipogénèse et ses répercussions sur l’inflammation in vitro et in vivo

May, P. (2018) · theses.fr (ABES) · doi:10.70675/daa4844fzf0ebz4e19z871dza0a46e6c14b7

β-catenin signaling, the constitutive androstane receptor and their mutual interactions

Braeuning, A., & Pávek, P. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02935-8 · Cited by 13 · see citing works

The time point of β-catenin knockout in hepatocytes determines their response to xenobiotic activation of the constitutive androstane receptor

Ganzenberg, K., Singh, Y., & Braeuning, A. (2013) · Toxicology · doi:10.1016/j.tox.2013.03.019 · Cited by 29 · see citing works

Abstract 2021: Mechanism of the coordinate regulation of liver cancer by nuclear receptor CAR and beta catenin

Dong, B., & Moore, D. D. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-2021

Activating CAR and β-catenin induces uncontrolled liver growth and tumorigenesis

Dong, B., Lee, J.-S., Park, Y.-Y., Yang, F., Xu, G., Huang, W., Finegold, M. J., & Moore, D. D. (2015) · Nature Communications · doi:10.1038/ncomms6944 · Cited by 97 · see citing works

Sex difference in the proliferative response of mouse hepatocytes to treatment with the CAR ligand, TCPOBOP

Columbano, A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg063 · Cited by 60 · see citing works